Home Featured Page 235

Featured

Latest

Podcast: Usona Files Psilocybin Application, We Review 610 Comments Submitted to FDA, and FDA Approves NRx’s Generic Ketamine

Usona Files Psilocybin for Depression NDA as Race With Compass Tightens

Jackie Tileston: Nondual Mysticism, 5-MeO-DMT, and the Trouble with Psychedelic Art

FDA Approves NRx’s Preservative-Free Generic Ketamine, but Its Bid to Ban Rivals’ Products Remains Pending

Weekly Psychedelic Policy Briefing: Oct. 27, 2026

COMPASS Pathways to launch phase II trial of COMP360 psilocybin therapy...

Mydecine Files Full Patent Application Covering New Formulations that Bring Nanoemulsion...

PharmaTher Enters into Research Collaboration Agreement with Revive Therapeutics for Development...

Psyched Wellness Announces That the Amanita Muscaria Mushroom Has Been Successfully...

Revive Therapeutics Enters into Research Collaboration Agreement with PharmaTher for Development...

Bright Minds Biosciences Commences Trading on the Nasdaq Under the Ticker...

Braxia Scientific Graduates First Cohort of Medical Professionals from Psilocybin-Assisted Therapy...

U.S. FDA Approves Nova Mentis Orphan Drug Application

Filament Health Announces FDA Authorization of Clinical Trial with First-Ever Direct...

Field Trip Health Ltd. Schedules Second Fiscal Quarter 2022 Financial Results...

EDITOR PICKS

Podcast: Usona Files Psilocybin Application, We Review 610 Comments Submitted to...

Usona Files Psilocybin for Depression NDA as Race With Compass Tightens

Jackie Tileston: Nondual Mysticism, 5-MeO-DMT, and the Trouble with Psychedelic Art

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Podcast: Usona Files Psilocybin Application, We Review 610 Comments Submitted to FDA, and FDA Approves NRx’s Generic Ketamine

Usona Files Psilocybin for Depression NDA as Race With Compass Tightens

Jackie Tileston: Nondual Mysticism, 5-MeO-DMT, and the Trouble with Psychedelic Art

FDA Approves NRx’s Preservative-Free Generic Ketamine, but Its Bid to Ban Rivals’ Products Remains Pending

Weekly Psychedelic Policy Briefing: Oct. 27, 2026

COMPASS Pathways to launch phase II trial of COMP360 psilocybin therapy...

Mydecine Files Full Patent Application Covering New Formulations that Bring Nanoemulsion...

PharmaTher Enters into Research Collaboration Agreement with Revive Therapeutics for Development...

Psyched Wellness Announces That the Amanita Muscaria Mushroom Has Been Successfully...

Revive Therapeutics Enters into Research Collaboration Agreement with PharmaTher for Development...

Bright Minds Biosciences Commences Trading on the Nasdaq Under the Ticker...

Braxia Scientific Graduates First Cohort of Medical Professionals from Psilocybin-Assisted Therapy...

U.S. FDA Approves Nova Mentis Orphan Drug Application

Filament Health Announces FDA Authorization of Clinical Trial with First-Ever Direct...

Field Trip Health Ltd. Schedules Second Fiscal Quarter 2022 Financial Results...

EDITOR PICKS

Podcast: Usona Files Psilocybin Application, We Review 610 Comments Submitted to...

Usona Files Psilocybin for Depression NDA as Race With Compass Tightens

Jackie Tileston: Nondual Mysticism, 5-MeO-DMT, and the Trouble with Psychedelic Art

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY